Related Experiment Video
Updated: Feb 10, 2026

08:26
Design of a Biocompatible Drug-Eluting Tracheal Stent in Mice with Laryngotracheal Stenosis
Published on: January 21, 2020
7.2K
[A Drug Delivery Device for Drug-eluting Stents Simulating the Cardiovascular Blood Flow Pattern].
Summary
A new device accurately simulates cardiovascular blood flow to measure drug release from drug-eluting stents. This validated method precisely predicts in vivo drug release rates.
Area of Science:
- Biomedical Engineering
- Pharmacokinetics
- Cardiovascular Devices
Background:
- Drug-eluting stents (DES) are crucial in treating coronary artery disease.
- Accurate prediction of in vivo drug release kinetics is essential for DES efficacy and safety.
- Existing in vitro methods may not fully replicate complex cardiovascular hemodynamics.
Purpose of the Study:
- To introduce a novel drug delivery device that simulates cardiovascular blood flow patterns.
- To validate this device as a reliable method for assessing in vivo drug release from DES.
Main Methods:
- Development of a novel drug delivery device mimicking cardiovascular blood flow.
- Simulation of in vivo drug release profiles within drug-eluting stents using the device.
- Comparison of device-generated release rates with in vivo measurements.
Main Results:
- The device successfully simulated cardiovascular blood flow patterns.
- Drug release rate results from the device correlated with in vivo measurements.
- The device demonstrated high fidelity in predicting in vivo drug release.
Conclusions:
- The novel device is a validated and effective tool for measuring in vivo drug release rates from drug-eluting stents.
- This simulation method offers a more accurate in vitro alternative for drug release assessment.
- The findings support the use of this device in optimizing DES development and evaluation.
More Related Videos
Related Concept Videos
Drug Delivery: Overview
900
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
900
Drug Delivery: Enteral Route
1.8K
The enteral drug administration involves three primary routes: oral, sublingual, and buccal. Oral ingestion is the most prevalent, safe, economical, and convenient method for drug administration. However, it has certain drawbacks, including limited absorption due to the drug's low water solubility or poor membrane permeability, possible emesis from GI mucosa irritation, destruction of drugs by digestive enzymes or low gastric pH, and irregular absorption along with food or other drugs.
1.8K
Drug Delivery: Parenteral Route
1.8K
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
1.8K
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
248
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
248
Drug Delivery: Miscellaneous Routes
836
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
836
Renal Drug Excretion: Effect of Urine pH, Flow Rate, and Drug pKa
598
The pH of urine, the drug's pKa, and the urine flow rate are vital parameters for drug reabsorption and excretion. Urinary pH varies between 4.6 and 8.0 and is influenced by diet, drug intake, and the patient's pathophysiology. It affects a drug's ionization state and reabsorption. For instance, carbohydrate-rich food produces alkaline urine promoting drug excretion, while proteins and certain medications like ascorbic acid lead to acidic urine enhancing reabsorption.
The pKa of a...
The pKa of a...
598

